Literature DB >> 32065168

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens.

Sanne Lof1, Rushda Rajak2, Frederique L I M Vissers3, Maarten Korrel3, Adrian Bateman2, Johanna Verheij4, Caroline Verbeke5, Ivana Cataldo6, Marc G Besselink3, Mohammed Abu Hilal7.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignant cancers. A minority (20%) of PDACs are found in the pancreatic body and tail. Accurate pathology assessment of the pancreatic specimen is essential for providing prognostic information and it may guide further treatment strategies. The recent 8th edition of the American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) staging system for pancreatic tumors has incorporated significant changes to tumor (pT) stage, which is predominantly based on tumor size. This change emphasizes the importance of careful block selection. Owing to the greater prevalence of tumors in the head of the pancreas, efforts are made to standardize the assessment of pancreatoduodenectomy specimens. However, consensus regarding the macroscopic assessment of distal (i.e., left) pancreatectomy specimens is lacking. The DIPLOMA approach includes the standardized measurement of pancreas and other resected organs, inking of relevant surgical margins and anatomical surfaces without removing covering layers of fat, measurement of tumor size (for T-stage), together with assessment of splenic vessel involvement (and other organs if present). All relevant margins are assessed, and relevant blocks are selected to confirm these parameters microscopically. The current protocol describes a standardized approach to the macroscopic assessment of distal pancreatectomy specimens. This approach was developed during several meetings with pathologists and surgeons during the preparation phase for an international multicenter trial (DIPLOMA, ISRCTN44897265), which focuses on radicality of distal pancreatectomy for pancreatic ductal adenocarcinoma. This standardized approach can be instrumental in the design of studies and will uniform reporting on the outcomes of distal pancreatectomy. The described technique is used in the DIPLOMA trial for pancreatic ductal adenocarcinoma but may also be useful for other indications.

Entities:  

Year:  2020        PMID: 32065168     DOI: 10.3791/60343

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  4 in total

1.  Tumour Size and T-Stage in Pancreatic Cancer Resection Specimens Depend on the Pathology Examination Approach.

Authors:  My Linh Tran; Maia Blomhoff Holm; Caroline Sophie Verbeke
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

Review 2.  Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal Adenocarcinoma.

Authors:  Maia Blomhoff Holm; Caroline Sophie Verbeke
Journal:  Curr Oncol       Date:  2022-09-14       Impact factor: 3.109

3.  ASO Author Reflections: Resection Margins in Distal Pancreatectomy for Ductal Adenocarcinoma-Does Surgery Tell the Whole Story?

Authors:  Mushegh A Sahakyan; Knut Jørgen Labori; Bjørn Edwin
Journal:  Ann Surg Oncol       Date:  2021-07-24       Impact factor: 5.344

4.  Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma.

Authors:  Mushegh A Sahakyan; Caroline S Verbeke; Tore Tholfsen; Dejan Ignjatovic; Dyre Kleive; Trond Buanes; Kristoffer Lassen; Bård I Røsok; Knut Jørgen Labori; Bjørn Edwin
Journal:  Ann Surg Oncol       Date:  2021-07-22       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.